Canopy Partners, LLC Astrazeneca PLC Transaction History
Canopy Partners, LLC
- $232 Billion
- Q3 2024
A detailed history of Canopy Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Canopy Partners, LLC holds 4,983 shares of AZN stock, worth $330,871. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,983
Previous 5,759
13.47%
Holding current value
$330,871
Previous $449 Million
13.56%
% of portfolio
0.17%
Previous 0.21%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.18 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.79 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.28 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...